Abstract
With the increasing focus on management of health-careassociated infections (HCAIs) and recognition of the cost of this complication which is frequently related to wounds, the development of new patient friendly products to prevent and control infection are becoming a standard item within most wound care practitioners’ tool kit. While the high quality Grade 1 randomized control trial (RCT) -based evidence may be lacking, we must not ignore the evidence gleaned from our own experiences and be aware of broader patient focussed outcomes than just wound healing. Wound infection is hugely expensive both financially and to the patient in terms of pain and suffering so prevention and management of it must become a priority in wound management objectives.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
